105 related articles for article (PubMed ID: 3756861)
1. Induction of tumor immunity and natural killer cell cytotoxicity in mice by 5-halo-6-phenyl pyrimidinone.
Lotzová E; Savary CA; Pollack S; Hanna N
Cancer Res; 1986 Oct; 46(10):5004-8. PubMed ID: 3756861
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
Lotzová E; Savary CA; Lowlachi M; Murasko DM
J Immunol; 1986 Jan; 136(2):732-40. PubMed ID: 2416824
[TBL] [Abstract][Full Text] [Related]
3. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
Lotzová E; Savary CA; Stringfellow DA
J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J
Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654
[TBL] [Abstract][Full Text] [Related]
5. Pyrimidinones: inducers of NK cell activity and antitumor immunity.
Lotzová E; Savary CA
Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):185-91. PubMed ID: 3791954
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
7. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Milas L; Hersh EM; Stringfellow DA; Hunter N
J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
[TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cells against tumor growth in nude mice--a brief review.
Habu S; Fukui H; Shimamura K; Kasai M; Okumura K; Tamaoki N
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):465-8. PubMed ID: 6681342
[TBL] [Abstract][Full Text] [Related]
9. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
Weinhold KJ; Bolognesi DP; Matthews TJ
J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
[TBL] [Abstract][Full Text] [Related]
10. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
11. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
Barlozzari T; Reynolds CW; Herberman RB
J Immunol; 1983 Aug; 131(2):1024-7. PubMed ID: 6863925
[TBL] [Abstract][Full Text] [Related]
12. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
13. Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.
Kato M; Kawauchi H; Taniguchi K; Katsuki T; Nomoto K
J Clin Lab Immunol; 1985 Jan; 16(1):47-51. PubMed ID: 3872372
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
15. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738) in the potentiation of natural killer cells.
Wang BS; Lumanglas AL; Silva J; Ruszala-Mallon VM; Durr FE
J Immunol; 1986 Oct; 137(8):2640-5. PubMed ID: 3760570
[TBL] [Abstract][Full Text] [Related]
18. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
Barlozzari T; Leonhardt J; Wiltrout RH; Herberman RB; Reynolds CW
J Immunol; 1985 Apr; 134(4):2783-9. PubMed ID: 3871818
[TBL] [Abstract][Full Text] [Related]
20. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
